...一种异物有致血栓形成和异物反应性,经大规模多中心研究结果显示,再狭窄率仍达22%一32%阴,预防和治疗支架再狭窄(Stent Restenosis,sRs)成为目前冠心病介入治疗领域的研究热点,药物洗脱支架(nmg Eluting stent,DES)的临...
基于4个网页-相关网页
随着对冠状动脉介入治疗后再狭窄机理研究的进展和涂层支架技术的研发成功，使药物涂层支架预防再狭窄成为可能。
With the progress of studying restenosis mechanism after coronary interventions therapy and successness of coated stent technology, it is possible to prevent from the restenosis by coated stents.
目的：探讨糖尿病合并冠心病老年患者支架植入术后三联抗血小板治疗对预防支架内血栓形成和再狭窄的有效性及安全性。
Objective: To investigate the safety and efficacy of triple antiplatelet therapy in aged patients with diabetes mellitus combined with coronary heart disease after percutaneous coronary intervention.
应用推荐